Key Metrics
CiteScore 

9
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
Scite Index 

0.89 5-Year SI

SJR 

Q1Neurology

SNIP 

1
Recommended pre-submission checks
Powered by 

Topics Covered on Alzheimer's Research and Therapy
Alzheimer's Research and Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | Springer Nature |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | GBP 2390 | USD 3590 |
| Publication Time | 16 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Alzheimer's Disease International |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Alzheimer's Research and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Alzheimer's Research and Therapy
Semantic fluency predicts survival of memory clinic patients.
- 7 Aug 2026
- Alzheimer's research & therapy
SuperAging is not the inverse of common-variant Alzheimer\u2019s risk: evidence across genetic ancestries
- 23 Jul 2026
- Alzheimer's Research & Therapy
Personalized non-invasive combined magnetic and electrical stimulation of the default mode network in mild AD patients (CMES-AD): a multicentric randomized sham-controlled trial protocol.
- 21 Jul 2026
- Alzheimer's research & therapy
Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer's disease.
- 17 Jul 2026
- Alzheimer's research & therapy
Blood-based immunophenotyping of T cell profiles in patients with neurodegenerative disorders.
- 16 Jul 2026
- Alzheimer's research & therapy
Sequential associations of myelin dysfunction with Aβ and Tau pathology in Alzheimer's disease: a dynamic myelin perturbation.
- 15 Jul 2026
- Alzheimer's research & therapy
Semantic fluency predicts survival of memory clinic patients.
- 7 Aug 2026
- Alzheimer's research & therapy
SuperAging is not the inverse of common-variant Alzheimer\u2019s risk: evidence across genetic ancestries
- 23 Jul 2026
- Alzheimer's Research & Therapy
Personalized non-invasive combined magnetic and electrical stimulation of the default mode network in mild AD patients (CMES-AD): a multicentric randomized sham-controlled trial protocol.
- 21 Jul 2026
- Alzheimer's research & therapy
Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer's disease.
- 17 Jul 2026
- Alzheimer's research & therapy
Blood-based immunophenotyping of T cell profiles in patients with neurodegenerative disorders.
- 16 Jul 2026
- Alzheimer's research & therapy
Sequential associations of myelin dysfunction with Aβ and Tau pathology in Alzheimer's disease: a dynamic myelin perturbation.
- 15 Jul 2026
- Alzheimer's research & therapy